查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1675288

龐貝氏症治療市場按治療、給藥途徑、配銷通路、適應症類型和地區分類 2025-2033 年

Pompe Disease Treatment Market by Treatment, Route of Administration, Distribution Channel, Indication Type, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球龐貝氏症治療市場規模達到 10.7 億美元。臨床研究的不斷增加和酵素替代療法（ERT）的日益普及正在刺激市場的發展。

龐貝氏症是一種遺傳性疾病，由人體細胞中被稱為肝醣的複合糖堆積引起，會影響器官、組織和肌肉。它是一種體染色體隱性遺傳的糖原累積症候群，因溶酶體酶酸性α-葡萄糖苷酶（GAA）缺乏引起。它與肌肉無力、肝臟腫大、呼吸困難、聽力問題、肺部感染、心律不整和體重減輕有關。它可以透過各種工具和測試來診斷，包括肌電圖、X光和磁振造影（MRI）。龐貝氏症可以透過藥物、酵素替代療法（ERT）、底物減少療法（SRT）、分子伴侶替代療法（CART）和注射等方式治療，有助於改善生活品質。

龐貝氏症治療市場趨勢：

個體中遺傳異常的盛行率大幅上升，患有龐貝氏症的患者數量也在增加。再加上嬰兒龐貝氏症的增加以及父母對新生兒健康的日益擔憂，這是推動市場成長的關鍵因素之一。此外，易患這些疾病的老年人口不斷成長，導致對龐貝氏症治療的需求不斷增加。此外，用於開發龐貝氏症新療法的臨床研究和試驗的數量不斷增加，也對市場產生了積極影響。除此之外，人們對 ERT 治療龐貝氏症的認知不斷提高，有利於市場成長。此外，由於各種治療方法具有許多優點，人們對其的認知也越來越高，包括幹細胞移植、骨髓移植、化療和免疫療法。這一現象加上人們對 ERT 治療替代品（如 lumizyme）的易得性的認知，為市場帶來了積極的前景。除此之外，越來越多的人採用健康保險政策，為龐貝氏症治療提供經濟援助並盡量減少醫療支出。此外，許多國家的政府和非政府組織 (NGO) 正在採取措施，為所有人提供優質的醫療設施。這一點，加上診斷技術的重大改進，預計將為市場帶來良好的前景。

本報告解答的關鍵問題

  • 龐貝氏症治療市場有多大？龐貝氏症治療市場未來前景如何？
  • 推動龐貝氏症治療市場的關鍵因素有哪些？
  • 哪個地區佔據龐貝氏症治療市場的最大佔有率？
  • 全球龐貝氏症治療市場領先的公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球龐貝氏症治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第6章：市場區隔：依處理方式

  • 酵素替代療法 (ERT)
  • 底物減量療法 (SRT)
  • 伴侶-高級替代療法 (CART)
  • 其他

第7章：市場區隔：依行政途徑分類

  • 口服
  • 靜脈
  • 其他

第 8 章：市場區隔：按配銷通路

  • 醫院和診所藥房
  • 零售藥局
  • 網路藥局
  • 其他

第9章：市場區隔：依適應症類型

  • 嬰兒型龐貝氏症 (IOPD)
  • 經典嬰兒模型
  • 非經典嬰兒模型
  • 晚髮型龐貝氏症 (LOPD)
  • 其他

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：促進因素、限制因素與機遇

  • 概述
  • 驅動程式
  • 限制
  • 機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amicus Therapeutics Inc.
    • Audentes Therapeutics Inc. (Astellas US Holding Inc.)
    • Oxyrane UK Limited
    • Sanofi SA
    • Spark Therapeutics Inc.
Product Code: SR112025A6708

The global Pompe disease treatment market size reached USD 1.07 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.33 Billion by 2033, exhibiting a growth rate (CAGR) of 2.47% during 2025-2033. The increasing number of clinical research and the growing popularity of enzyme replacement therapy (ERT) are stimulating the market.

Pompe disease is a genetic disorder caused by the buildup of a complex sugar known as glycogen in the cells of the body, which affects organs, tissues, and muscles. It is an autosomal recessive glycogen storage syndrome caused by the deficiency of lysosomal enzyme acid a-glucosidase (GAA). It is associated with weak muscles, enlarged liver, trouble breathing, hearing problem, lung infection, irregular heartbeat, and losing weight. It is diagnosed using various tools and tests, including electromyography, X-rays, and magnetic resonance imaging (MRI). Pompe disease can be treated using medications, enzyme replacement therapy (ERT), substrate reduction therapy (SRT), chaperone-advanced replacement therapy (CART), and injections, which aid in improving the quality of life.

Pompe Disease Treatment Market Trends:

There is a considerable rise in the prevalence of genetic abnormalities among individuals and an increase in the number of patients suffering from Pompe disease. This, coupled with the growing Pompe disease among infants and increasing concerns among parents about the health of their newborns, represents one of the key factors bolstering the growth of the market. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is resulting in an increasing demand for Pompe disease treatment. In addition, the expanding number of clinical studies and trials to develop new treatments for Pompe disease is influencing the market positively. Apart from this, the rising awareness among people about ERT for curing Pompe disease is favoring the market growth. Furthermore, there is an increase in awareness about various treatments, including stem cell transplant, bone marrow transplantation, chemotherapy, and immunotherapy, on account of their numerous advantages. This, along with the awareness about the easy availability of ERT treatment alternatives like lumizyme, is creating a positive outlook for the market. Besides this, there is a rise in the adoption of health insurance policies that provide financial assistance and minimize healthcare expenditure for Pompe disease treatment. Additionally, governments and non-governmental organizations (NGOs) of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is anticipated to provide a favorable outlook to the market.

Key Market Segmentation:

Treatment Insights:

  • Enzyme Replacement Therapy (ERT)
  • Substrate Reduction Therapy (SRT)
  • Chaperone-Advanced Replacement Therapy (CART)
  • Others

Route of Administration Insights:

  • Oral
  • Intravenous
  • Others

Distribution Channel Insights:

  • Hospital and Clinics Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Indication Type Insights:

  • Infantile-Onset Pompe Disease (IOPD)
  • Classic Infantile Form
  • Non-Classic Infantile Form
  • Late-Onset Pompe Disease (LOPD)
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Pompe disease treatment. Some of the factors driving the North America Pompe disease treatment market included the growing awareness about various alternative treatments, increasing number of clinical studies and trials, and well-established healthcare facilities.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global Pompe disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amicus Therapeutics Inc., Audentes Therapeutics Inc. (Astellas US Holding Inc.), Oxyrane UK Limited, Sanofi S.A., Spark Therapeutics Inc, etc.

Key Questions Answered in This Report

  • 1.How big is the pompe disease treatment market?
  • 2.What is the future outlook of pompe disease treatment market?
  • 3.What are the key factors driving the pompe disease treatment market?
  • 4.Which region accounts for the largest pompe disease treatment market share?
  • 5.Which are the leading companies in the global pompe disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pompe Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment

  • 6.1 Enzyme Replacement Therapy (ERT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Substrate Reduction Therapy (SRT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Chaperone-Advanced Replacement Therapy (CART)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital & Clinics Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Indication Type

  • 9.1 Infantile-Onset Pompe Disease (IOPD)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Classic Infantile Form
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Non-Classic Infantile Form
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Late-Onset Pompe Disease (LOPD)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Amicus Therapeutics Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Audentes Therapeutics Inc. (Astellas US Holding Inc.)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Oxyrane UK Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Sanofi S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Spark Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

  • Figure 1: Global: Pompe Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Pompe Disease Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pompe Disease Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pompe Disease Treatment Market: Breakup by Treatment (in %), 2024
  • Figure 5: Global: Pompe Disease Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Pompe Disease Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Pompe Disease Treatment Market: Breakup by Indication Type (in %), 2024
  • Figure 8: Global: Pompe Disease Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Pompe Disease Treatment (Enzyme Replacement Therapy (ERT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Pompe Disease Treatment (Enzyme Replacement Therapy (ERT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Pompe Disease Treatment (Substrate Reduction Therapy (SRT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Pompe Disease Treatment (Substrate Reduction Therapy (SRT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Pompe Disease Treatment (Chaperone-Advanced Replacement Therapy (CART)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Pompe Disease Treatment (Chaperone-Advanced Replacement Therapy (CART)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Pompe Disease Treatment (Other Treatments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Pompe Disease Treatment (Other Treatments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Pompe Disease Treatment (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Pompe Disease Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Pompe Disease Treatment (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Pompe Disease Treatment (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Pompe Disease Treatment (Other Rout of Administrations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Pompe Disease Treatment (Other Rout of Administrations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Pompe Disease Treatment (Hospital & Clinics Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Pompe Disease Treatment (Hospital & Clinics Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Pompe Disease Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Pompe Disease Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Pompe Disease Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Pompe Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Pompe Disease Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Pompe Disease Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Pompe Disease Treatment (Infantile-Onset Pompe Disease (IOPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Pompe Disease Treatment (Infantile-Onset Pompe Disease (IOPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Pompe Disease Treatment (Classic Infantile Form) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Pompe Disease Treatment (Classic Infantile Form) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Pompe Disease Treatment (Non-Classic Infantile Form) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Pompe Disease Treatment (Non-Classic Infantile Form) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Pompe Disease Treatment (Late-Onset Pompe Disease (LOPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Pompe Disease Treatment (Late-Onset Pompe Disease (LOPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Pompe Disease Treatment (Other Indication Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Pompe Disease Treatment (Other Indication Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Pompe Disease Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Pompe Disease Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Pompe Disease Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Pompe Disease Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 91: Global: Pompe Disease Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Pompe Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pompe Disease Treatment Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Pompe Disease Treatment Market Forecast: Breakup by Treatment (in Million USD), 2025-2033
  • Table 3: Global: Pompe Disease Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Pompe Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Pompe Disease Treatment Market Forecast: Breakup by Indication Type (in Million USD), 2025-2033
  • Table 6: Global: Pompe Disease Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Pompe Disease Treatment Market: Competitive Structure
  • Table 8: Global: Pompe Disease Treatment Market: Key Players